Evidence map›Paper›PMID 40707932›Full record

ReviewJournal of nanobiotechnology2025

A comprehensive review of unlocking the potential of lignin-derived biomaterials: from lignin structure to biomedical application.

Jixiang Zhao, Minyu Zhu, Wei Jin, Jinlan Zhang, Guangyu Fan, Yifan Feng, Zhuo Li, Siming Wang, Jung Seung Lee, Guangxiang Luan and 2 more

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jixiang Zhao *Department of Pharmacy, Medical College, Qinghai University, Xining, 810016, PR China.
Minyu Zhu *Department of Pharmacy, Medical College, Qinghai University, Xining, 810016, PR China.
Wei JinState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing, 100193, PR China.
Jinlan ZhangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing, 100193, PR China.
Guangyu FanState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing, 100193, PR China.
Yifan FengState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing, 100193, PR China.
Zhuo LiState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing, 100193, PR China.
Siming WangNortheast Asian Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, PR China.
Jung Seung LeeDepartment of Biomedical Engineering, Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.
Guangxiang LuanDepartment of Pharmacy, Medical College, Qinghai University, Xining, 810016, PR China. 2020990022@qhu.edu.cn.
Zhengqi DongDepartment of Pharmacy, Medical College, Qinghai University, Xining, 810016, PR China. zqdong@implad.ac.cn.
Ying LiDepartment of Pharmacy, Medical College, Qinghai University, Xining, 810016, PR China. yli@implad.ac.cn.

Funding

Chinese Academy of Medical Sciences 2022-12M-1-018Chinese Academy of Medical Sciences 2022-12M-2-001Jilin Provincial Scientific and Technological Development Program 20230401102YYNational Natural Science Foundation of China 82304733Qinghai University 2023-kyt-1
6 · The paper itself

Abstract

Inspired by natural organisms, biomimetic materials with exceptional biocompatibility, degradability, and multifunctionality have emerged as promising candidates for biomedical applications. Lignin, a plant-derived organic polymer, has gained attention due to its intrinsic antioxidant activity, adhesive properties, and biocompatibility. Despite its structural advantages, challenges in stability, biodegradability, and practical implementation hinder its utilization. Structural modifications through chemical/physical treatments or microbial/enzymatic can optimize lignin's bioactivity, mechanical strength, and adhesion, enabling applications in drug delivery, Ultraviolet (UV) shielding, sensing, and wound healing. This review outlines lignin sources, modification principles, and adhesion of biomaterials mechanisms, while showcasing innovative lignin-based materials in biomedical contexts. We highlight their roles in therapeutic delivery systems, tissue engineering & regenerative medicine, and functional biomedical devices, emphasizing lignin's low toxicity and environmental adaptability. By addressing current limitations in processing techniques and clinical translation, we discuss lignin's potential to bridge laboratory research and practical medical solutions. The analysis concludes with an evaluation of lignin's untapped value in sustainable biomedicine, proposing strategies to overcome scalability and standardization barriers. This synthesis provides critical insights for advancing lignin-based technologies toward clinical implementation while maintaining ecological sustainability.

Indexed as

Biocompatible MaterialsLigninAnimalsDrug Delivery SystemsHumansRegenerative MedicineTissue EngineeringBiocompatible MaterialsLignin

Identifiers

PMID40707932
PMCPMC12288329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.